How splicing confers treatment resistance in prostate cancer
Prathyusha Konda, Srinivas R Viswanathan
eLife · 2022
doi:10.7554/elife.82070 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
A splice variant of the androgen receptor that drives prostate cancer resistance translocates into the nucleus using a different mechanism from the full-length receptor and exhibits distinct molecular properties once inside.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.